Cargando…
Overcoming immune-cell unresponsiveness in cancer
Autores principales: | Lametschwandtner, Guenther, Ermann, Monika, Sternberger, Ina, Hesterkamp, Thomas, Haslinger, Isabella, Mühleisen, Hannes, Schuster, Manfred, Loibner, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990340/ http://dx.doi.org/10.1186/2051-1426-1-S1-P261 |
Ejemplares similares
-
Cbl-b silenced human NK cells respond stronger to cytokine stimulation
por: Lametschwandtner, Guenther, et al.
Publicado: (2015) -
Development of a personalized cellular ex-vivo cbl-b silencing cancer immunotherapy
por: Lametschwandtner, Guenther, et al.
Publicado: (2014) -
Treatment of a cancer patient by an adoptive cell therapy protocol combining DC vaccination with cbl-b ex vivo silencing
por: Sachet, Monika, et al.
Publicado: (2015) -
Phase I clinical trial of adoptive cellular immunotherapy with APN401 in patients with solid tumors
por: Triozzi, Pierre, et al.
Publicado: (2015) -
Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients
por: Lode, Holger, et al.
Publicado: (2013)